Clinical surveillance of circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) using liquid biopsy and proliferation/apoptosis indicators (Ki-67, M30) may facilitate the prediction of late relapse risk, as dormant CTCs are more common among individuals with delayed recurrence [184,185,191,193]. The gene discussed is MKI67; the disease is neoplasm.